COVID-19 infection among nursing personnel: a retrospective survey in Kolkata, West Bengal

Uma Rani Adhikari, Shampa Gupta, Soumi Bhattacharjee


Background: During this COVID-19 pandemic the health care workers are at greatest risk of exposure and subsequently developing SARS-CoV-2 infection. Multiple factors determine the severity of illness and its prognosis. This study aims to assess the incidence and severity of COVID-19 infection among the nursing personnel in Kolkata, West Bengal and determines the factors in severity of COVID-19 infection in the reported positive case.

Methods: A cross sectional survey was carried out among 858 nursing personnel in Kolkata, West Bengal from April 2021 to March 2022. Demographic and clinical data were collected through semi structured questionnaire and they were tested for validity and reliability before data collection.

Results: Result showed that 12.9% nursing personnel are COVID-19 affected. 66.7% belonged to the age group 18-25 years, 100% female and 73% were single. Out of 111 COVID-19 affected, 36.9% were fully vaccinated and 8.1% were partially vaccinated before COVID-19 infection, 16.2% were having comorbidity. Exposure source was not known for 74.8% and from the 25.2% known exposure cases 53.6% developed symptoms in <1 week. 45.9% suffered 2-3 weeks and 33.3% were having some post COVID-19 health problem. Data revealed that severity of illness was significantly associated with comorbidity (X2=5.820) and vaccination status (X2=7.058). Post COVID-19 health problem was significantly associated with age (X2=12.586), comorbidity (X2=12.538) and vaccination status (X2=17.838).

Conclusions: Occurrence and severity of COVID-19 infection is less in vaccinated cases. Age, comorbidity and vaccination are the important factors in severity and developing post COVID-19 health problem.


COVID-19 infection, Vaccination, Severity, Post COVID health problem, Nursing personnel

Full Text:



Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141-54.

Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020;91(1):157-60.

Worldmeter. Coronavirus cases, 2022. Available at: › coronavirus. Accessed on 30 April 2022.

Bandyopadhyay S, Baticulon RE, Kadhum M, Alser M, Ojuka DK, Badereddin Y et al. Infection and mortality of healthcare. BMJ Global Health. 2020;5:e003097.

Sabetian G, Moghadami M, Haghighi HFL, Shahriarirad R, Fallahi MJ, Asmarian N et al. COVID-19 infection among healthcare workers: a cross-sectional study in southwest Iran. Virol J. 2021;18(1):58.

MOHW. COVID-19 Vaccines operational guideliness, 2021. Available at: › pdf › COVIDVaccin. Accessed on 30 April 2022.

Victor PJ, Mathews KP, Paul H, Mammen JJ, Murugesan M. Protective Effect of COVID-19 Vaccine Among Health Care Workers During the Second Wave of the Pandemic in India. Mayo Clin Proc. 2021;96(9):2493-4.

Antonelli M, Penfold RS, Merino J, Sudre CH, Molteni E, Berry S et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22(1):43-55.

Strake KR, Reissig D, Petereit-Haack G, Schmauder S, Nienhaus A, Seidler A. The isolated effect of age on the risk of ;COVID-19 severe outcomes: a systematic review with meta-analysis. BMJ Global Health. 2021;6:e006434.

Chodick G, Tene L, Patalon T, Gazit S, Ben Tov A, Cohen D et al. Assessment of Effectiveness of 1 Dose of BNT162b2 Vaccine for SARS-CoV-2 Infection 13 to 24 Days After Immunization. JAMA Netw Open. 2021;4(6):e2115985.

Andrews N, Stowe J, Kirsebom F, Toffa S, Rickeard T, Gallagher E et al. Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant. N Engl J Med. 2022;NEJMoa2119451.

Chandan OC, Facciorusso A. Postvaccination SARS-CoV-2 infection among healthcare workers: A systematic review and meta-analysis. J Med Virol. 2022;94(4):1428-41.

Silva S, Mana T, Bhullar D, Tabor B, Donskey C. Evaluation of Exposure History in Healthcare Personnel with Coronavirus 2019 Disease. Open Forum Infectious Diseases. 2020;7(1):293.

Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med. 2020;172(9):577-82.

Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91-5.

Mayo Clinic. COVID-19 (coronavirus): Long-term effects, 2021. Available at: Accessed on 30 April 2022.

Goërtz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Felipe VCM et al. A. Spruit. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Research. 2020;6(4)00542-2020.

Al Khathlan N, Padhi BK. Adherence to COVID-19 Appropriate Behavior Among Respiratory Therapists: A Cross-Sectional Study in the Kingdom of Saudi Arabia. Front Public Health. 2021;9:715982.

CDC. Symptoms of COVID-, 2021. Available at: › 2019-ncov › symptoms-testing. Accessed on 30 April 2022.

ICMR. Evidence Based Advisory on Correlation of COVID-19 Disease Severity with Ct Values of the Real Time RT-PCR Test, 2021. Available at: › pdf › covid › techdoc. Accessed on 30 April 2022.

Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P et al. Comorbidity and its Impact on Patients with COVID-19. SN ComprClin Med. 2020;2(8):1069-76.

Kuodi P, Gorelik Y, Zayyad H, Wertheim O, Wiegler KB, Jabal KA et al. Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: a cross-sectional study of patients infected between March 2020 and November 2021. medRxiv. 2022;01.05.22268800.